NovaGo Therapeutics
Series ASchlieren, SwitzerlandJan 2019
NovaGo Therapeutics raised €8.9M in a Series A round in Jan 2019. The company is based in Schlieren, Switzerland. Investors in the round: Neurimmune Holding, Pureos Bioventures. Data as of 4 Nov 2026.
Amount raised
€8.9M
€8,873,902
Native amount
10,000,000 CHF
Stage
Series A
series a
Investors
2
Provenance & confidence
High confidenceAmount
10,000,000 CHF
ECB-at-date → €8.9M · rate 1.1269 on 2018-12-31
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
2 namedDate
Jan 2019
Round type
series a
Amount (EUR)
€8.9M